glofitamab,Obinutuzumab 
roche
['dlbcl', 'glofitamab', 'car-t', 'pivotal', '$rhhby']
michael dickinson on $rhhby glofitamab in dlbcl (30% post car-t), pivotal dose expansion #asco22 
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.